D T Jamison

Dados Biográficos

ID176992
NOMED T Jamison
PRENOMESD T
SOBRENOMEJamison
ASSINATURAJAMISON D T
AFILIAÇÕESUniversity of California, San Francisco
ORCID0000-0003-4387-6064
VERIFICADOSim
TOTAL DE OBRAS31
TOTAL DE CITAÇÕES116
TOTAL COMO AUTOR31
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO1970
ANO MAIS RECENTE DE PUBLICAÇÃO2025
ÍNDICE H6

  • Global Disparities in Premature Mortality

    Open AccessØ Karlsson, D T Jamison et al.ARTICLEJAMA Health Forum2025

    In this cross-sectional study, disparities in PPD were likely to reflect major inequality in access to health-enhancing technologies and living standards, as well as context-specific obstacles. Technological and medical advancements leading to universal health benefits need to be rapidly and fairly disseminated

  • One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and Covid-19

    Open AccessAlenda Y Chang, Peter Aaby et al.ARTICLEFrontiers in Public Health2022

    Introduction: Recent reviews summarize evidence that some vaccines have heterologous or non-specific effects (NSE), potentially offering protection against multiple pathogens. Numerous economic evaluations examine vaccines' pathogen-specific effects, but less than a handful focus on NSE. This paper addresses that gap by reporting economic evaluations of the NSE of oral polio vaccine (OPV) against under-five mortality and COVID-19. Materials and m…

  • Country performance against Covid-19

    Open AccessD T Jamison, Lawrence J Lau et al.ARTICLEBMJ Global Health2020

    OBJECTIVE: To generate rankings of 35 countries from all continents (except Africa) on performance against COVID-19. DESIGN: International time series, cross-sectional analysis. SELECTED COUNTRIES: Countries having 5500 or more cases (collectively including 85% of the world's cases) as of 16 April 2020 and that had reached 135 days into their pandemic by 30 July. MAIN OUTCOME MEASURES: performance rankings based on doubling time in days of the to…

  • Protecting essential health services in low-income and middle-income countries and humanitarian settings while responding to the Covid-19 pandemic

    Open AccessKarl Blanchet, Ala Alwan et al.ARTICLEBMJ Global Health2020

    In health outcomes terms, the poorest countries stand to lose the most from these disruptions. In this paper, we make the case for a rational approach to public sector health spending and decision making during and in the early recovery phase of the COVID-19 pandemic. Based on ethics and equity principles, it is crucial to ensure that patients not infected by COVID-19 continue to get access to healthcare and that the services they need continue t…

  • Valuing Protection against Health-Related Financial Risks

    Open AccessJames S Skinner, K Chalkidou et al.ARTICLEJournal of Benefit-Cost Analysis2019Referências: 5

    There is strong interest in both developing and developed countries towards expanding health insurance coverage. How should the benefits, and costs, of expanded coverage be measured? While the value of reducing the financial risks that result from insurance coverage have long been recognized, there has been less attention in how best to measure such benefits. In this paper, we first provide a framework for assessing the financial value from healt…

  • Standardized Sensitivity Analysis in BCA

    Open AccessElina Pradhan, D T JamisonARTICLEJournal of Benefit-Cost Analysis2019Referências: 7

    Benefit-cost analyses of education policies in low- and middle-income countries have historically used the effect of education on future wages to estimate benefits. Strong evidence also points to female education reducing both the under-five mortality rates of their children and adult mortality rates. A more complete analysis would thus add the value of mortality risk reduction to wage increases. This paper estimates how net benefits and benefit-…

  • Conducting Benefit-Cost Analysis in Low- and Middle-Income Countries

    Open AccessLisa A Robinson, James K Hammitt et al.ARTICLEJournal of Benefit-Cost Analysis2019Citada por: 4Referências: 1

    Investing in global health and development requires making difficult choices about what policies to pursue and what level of resources to devote to different initiatives. Methods of economic evaluation are well established and widely used to quantify and compare the impacts of alternative investments. However, if not well conducted and clearly reported, these evaluations can lead to erroneous conclusions. Differences in analytic methods and assum…

  • Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage

    Open AccessFelicia M Knaul, Paul E Farmer et al.ARTICLEThe Lancet2018

  • Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals

    Open AccessRachel Nugent, Melanie Y Bertram et al.ARTICLEThe Lancet2018

  • How to convene an international health or development commission

    Open AccessGavin Yamey, Lawrence H Summers et al.ARTICLEHealth Policy and Planning2018Referências: 19

    The Commission on Investing in Health (CIH), an international group of 25 economists and global health experts, published its Global Health 2035 report in The Lancet in December 2013. The report laid out an ambitious investment framework for achieving a “grand convergence” in health—a universal reduction in deaths from infectious diseases and maternal and child health conditions—within a generation. This article captures ten key elements that the…

  • Comparative effectiveness of two disparate policies on child health

    Open AccessJohn W Peabody, John Peabody et al.ARTICLEHealth Policy and Planning2017Referências: 25

    BACKGROUND: Should health systems invest more in access to care by expanding insurance coverage or in health care services including improving the quality of care? Comparing these options experimentally would shed light on the impact and cost-effectiveness of these strategies. METHODS: The Quality Improvement Demonstration Study (QIDS) was a randomized policy experiment conducted across 30 districts in the Philippines. The study had a control gro…

  • Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa

    Open AccessDavid Watkins, David A Watkins et al.ARTICLEHealth Policy and Planning2016Citada por: 2Referências: 24

    The South African Government recently set targets to reduce cardiovascular disease (CVD) by lowering salt consumption. We conducted an extended cost-effectiveness analysis (ECEA) to model the potential health and economic impacts of this salt policy. We used surveys and epidemiologic studies to estimate reductions in CVD resulting from lower salt intake. We calculated the average out-of-pocket (OOP) cost of CVD care, using facility fee schedules …

  • Comparing the health and social protection effects of measles vaccination strategies in Ethiopia

    Open AccessJulia Driessen, Zachary D Olson et al.ARTICLESocial Science & Medicine2015Referências: 36

    Vaccination coverage rates often mask wide variation in access, uptake, and cost of providing vaccination. Financial incentives have been effective at creating demand for social services in a variety of settings. Using methods of extended cost-effectiveness analysis, we compare the health and economic implications of three different vaccine delivery strategies for measles vaccination in Ethiopia: i) routine immunization, ii) routine immunization …

  • Estimates of performance in the rate of decline of under-five mortality for 113 low- and middle-income countries, 1970–2010

    Open AccessStéphane Verguet, D T JamisonARTICLEHealth Policy and Planning2014Referências: 24

    UNLABELLED: BACKGROUND; Measuring country performance in health has focused on assessing predicted vs observed levels of outcomes, an indicator that varies slowly over time. An alternative is to measure performance in terms of the rate of change in how a selected outcome compares to what would be expected given contextual determinants. Rates of change in health indicators can prove more sensitive than levels to changes in social, intersectoral or…

  • Global health 2035

    Open AccessD T Jamison, Lawrence H Summers et al.ARTICLEThe Lancet2013

    countries can be reduced by 2035 through inexpensive population-based and clinical interventions. Fiscal policies are an especially promising lever for reducing this burden.

  • Impact of supplemental immunisation activity (SIA) campaigns on health systems

    Stéphane Verguet, Waasila Jassat et al.ARTICLEJournal of Epidemiology and…2013Citada por: 3Referências: 24

    BACKGROUND: Supplemental immunisation activity (SIA) campaigns provide children with an additional dose of measles vaccine and deliver other child health interventions including vitamin A supplements, deworming medications and oral polio vaccines. They also require the mobilisation of a large health workforce. We assess the impact of the implementation of SIA campaigns on selected routine child and maternal health services in South Africa (SA). M…

  • Characterizing the Amount and Speed of Discounting Procedures

    Open AccessD T Jamison, Julian JamisonARTICLEJournal of Benefit-Cost Analysis2011Citada por: 1Referências: 2

    This paper introduces the concepts of amount and speed of a discounting procedure in order to generate well-characterized families of procedures for use in social project evaluation. Exponential discounting sequesters the concepts of amount and speed into a single parameter that needs to be disaggregated in order to characterize nonconstant rate procedures. The inverse of the present value of a unit stream of benefits provides a natural measure o…

  • Public financing of health in developing countries

    Open AccessChunling Lu, Matthew Schneider et al.ARTICLEThe Lancet2010

  • Financing of global health

    Open AccessNirmala Ravishankar, Paul Gubbins et al.ARTICLEThe Lancet2009

  • Global and regional burden of disease and risk factors, 2001

    Open AccessAlan D Lopez, Clay Mathers et al.ARTICLEThe Lancet2006

  • Modeling the effects of health on economic growth

    Open AccessAlok Bhargava, D T Jamison et al.ARTICLEJournal of Health Economics2001

  • Education and economic growth Some cross-sectional evidence from Brazil

    Open AccessLawrence J Lau, D T Jamison et al.ARTICLEJournal of Development Economics1993Citada por: 6Referências: 7

  • Disease and Mortality in Sub-Saharan Africa

    Charles M Good, R G Feachem et al.ARTICLEAfrican Studies Review1993Citada por: 21

    This book marks the first step in a new review of health policy - a review that focuses specifically on sub - Saharan Africa. Several factors make this exercise particularly timely: 1) the concern that the economic downturn of the early 1980s may have adversely affected the health sector in Africa; 2) the need to evaluate the impact of primary health care strategies, especially the key elements of immunization and oral rehydration; 3) the complet…

  • Poliomyelitis

    Open AccessD T Jamison, Alberto M Torres‐Cantero et al.ARTICLEHealth Policy and Planning1991Citada por: 1

    The World Health Organization (WHO) estimates that 74% of the world's children were fully immunized against poliomyelitis by early 1990; even so, the disease is still paralysing almost a quarter of a million individuals each year and killing perhaps 25 000. This paper - one of a series undertaken on specific diseases for the World Bank's Health Sector Priorities Review on diseases of major importance in the developing world - reviews available ev…

  • Disease control priorities in developing countries

    D T Jamison, W Henry MosleyARTICLEAmerican Journal of Public Health1991Citada por: 18Referências: 21

    Health systems in developing countries are facing major challenges in the 1990s and beyond because of a growing epidemiological diversity as a consequence of rapid economic development and declining fertility. The infectious and parasitic diseases of childhood must remain a priority at the same time the chronic diseases among adults are emerging as a serious problem. Health policymakers must engage in undertaking an epidemiological and economic a…